Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

10 Results

Guidelines and Advice

Organizational Standards for Diagnostic Assessment Programs

Status: Archived
ID: DAP

Jun 2007

Guidelines and Advice

Comparison of PET/CT and PET/MR Imaging in Oncology

Status: Current
ID: ES PET 16
Version: 2

Apr 2024

Guidelines and Advice

Hereditary Cancer Testing Eligibility Criteria: Version 3.1

Status: Current
Version: 3.1

Oct 2024

Guidelines and Advice

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Status: Current
Version: 1.0

Jan 2024

Guidelines and Advice

An Endorsement of the 2021 Cancer Care Alberta Clinical Practice Guideline on Uveal Melanoma

Status: Current
ID: C50-CIDAP-1

Mar 2024

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2023

Status: Current
Version: PET 2023-2

Jun 2024

Guidelines and Advice

Organizational Guidance for the Care of Patients with Central Nervous System Tumours in Ontario: Consensus Recommendations

Status: Current
ID: GL 9-11

Oct 2024

Guidelines and Advice

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Status: Current
ID: Guideline Endorsement C50-CIDAP-2

Updated

Nov 2024

Guidelines and Advice

Organizational Requirements for Acute Leukemia Service Providers in Ontario: Recommendations Report 2024

Status: Current
Version: 2

Updated

Dec 2024

Guidelines and Advice

Endometrial Cancer Molecular Testing Recommendations Report

Status: Current
Version: 1

Updated

Nov 2024